Stockreport

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation [Yahoo! Finance]

Serina Therapeutics, Inc.  (SER) 
PDF developing its proprietary POZ Platform ™ drug delivery technology, today announced the appointment of Dr. Srini Tenjarla as the new Senior Vice President of CMC (Chemis [Read more]